55 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
of advancing both pediatric and adult medicines in areas of unmet need with equal urgency,” said Dr. Samuel Blackman, co-founder and head of research … and development at Day One. “We believe the linker-payload technology embodied in DAY301 will overcome the limitations of earlier PTK7-targeted ADCs
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
, management believes it has sufficient capital resources to fund anticipated operations into 2026.
R&D Expenses: Research and development expenses were $40.2 … shares)
Three Months Ended
March 31,
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
for this unique patient population truly evolved,” said Dr. Samuel Blackman, co-founder and head of research and development at Day One. “As a pediatric neuro
8-K
EX-99.1
tj6dzy363p
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
S-8
EX-99.1
dsys3x f8nz
4 Jan 24
Registration of securities for employees
4:06pm
8-K
EX-14.1
xhy kpniho760pj2bv
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
8-K
EX-99.1
99c9 p4g9t1eumml519w
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.1
txn805m 2eh
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
S-3ASR
00kjnsbmih84dop2h2u
14 Sep 23
Automatic shelf registration
5:28pm
8-K
EX-99.1
b44u3ja3ke
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.1
jflw6j8i71 vjb49ums
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-1.1
pogq4ha0 ybqf
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
wio65qi 1i
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
zzk5oe0jxa8g5vrdce
6 Jun 23
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.2
e5b1f0rz
5 Jun 23
Regulation FD Disclosure
6:08am